Gosset Ownership
Private
Employees
~25
Therapeutic Areas
Stage
Other
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Genzum Life Sciences General Information
Genzum Life Sciences specializes in developing high-barrier and complex generic pharmaceutical products. The company has completed at least one successful Phase 3 clinical trial demonstrating therapeutic equivalence of its topical naftifine hydrochloride cream to the branded product Naftin® in tinea pedis. Its business model focuses on precise reproduction of branded drugs as generics, with a strong emphasis on topical and sterile dosage forms.
Contact Information
Website
Primary Industry
Biotech
Corporate Office
Los Angeles, California
United States
United States
Drug Pipeline
No pipeline data available
Key Partnerships
Commercial partners for co-development, manufacturing, and marketing of generic pharmaceuticals; specific names not disclosed but includes leading pharmaceutical companies
Genzum Life Sciences Funding
No funding data available
To view Genzum Life Sciences's complete valuation and funding history, request access »